Excedrin

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Excedrin

What is Excedrin? Definition and Facts

Property Description
Active Ingredients Acetaminophen, Caffeine
Form Tablets or Caplets (Solid Oral)
Pharmacological Class Non-opioid Analgesic and CNS Stimulant Combination
Common Use Relief of General Pain, including Headache
Origin Synthetic

What Type of Medicine is Excedrin?

Excedrin is a widely recognized brand of an Over-the-Counter (OTC) combination drug, primarily classified as a non-opioid analgesic combination product. This specific formulation is distinguished by its fixed-dose combination of an analgesic and a central nervous system (CNS) stimulant. It is administered via oral administration in the form of a tablet or caplet. Its composition is intended for managing common discomforts, positioning it as a dedicated solution for general pain and headache relief.


What are the Active Ingredients in Excedrin?

The core therapeutic components are two synthetic active ingredients: Acetaminophen (Paracetamol) and Caffeine. Acetaminophen is the primary analgesic, chemically classified as a P-aminophenol derivative, while Caffeine is a methylxanthine derivative and mild CNS stimulant. This combination, which features two non-narcotic compounds, differentiates it from single-agent pain relievers. The medicine is typically positioned for the adult and adolescent patient group seeking reliable pain management.


Why are Acetaminophen and Caffeine Combined?

This product is formulated to maximize the therapeutic effect through synergism. Caffeine is incorporated as an analgesic adjunct, a supporting compound intended to increase the speed and efficacy of the Acetaminophen component. This design choice provides a more robust initial response to pain than the analgesic alone, offering a comprehensive approach for conditions such as tension headaches. This dual-action mechanism is the essential, differentiating feature of the brand.

Regulatory References

  1. DailyMed: EXCEDRIN EXTRA STRENGTH PAIN RELIEVER

What side effects are possible with Excedrin?

Possible Side Effects and Safety Information

The safety profile of this combination medicine (acetaminophen, aspirin, and caffeine) is primarily structured around the known toxicities and risks associated with its three components, as documented in official government regulatory sources.

Safety Considerations

Component Risk Focus Description of Concern (Based on Regulatory Classification)
Hepatotoxicity (Acetaminophen) The potential for severe liver damage or failure, which is dose-dependent and significantly increased by exceeding the recommended daily limit or concurrent use of alcohol or other acetaminophen-containing products.
Gastrointestinal (Aspirin) The risk of serious gastrointestinal bleeding, ulceration, or perforation. This risk is higher in the elderly, those with a history of ulcers, or individuals using blood thinners.
Hypersensitivity/Skin The documented potential for serious allergic reactions (including anaphylaxis) and life-threatening severe skin reactions (such as Stevens-Johnson syndrome) from both acetaminophen and aspirin.

Population and Use Restrictions

Official safety documents define specific limitations on use:

  • Pediatric/Adolescent Restriction: Aspirin use is contraindicated in children and teenagers recovering from or experiencing flu symptoms or chickenpox due to the association with Reye's syndrome, a rare but serious condition.
  • Dose-Related Risk: Strict adherence to the stated maximum daily dosage is required to mitigate the risk of dose-dependent liver damage.
  • Cardiovascular and Hemorrhagic Risk: The aspirin component is linked to an increased risk of bleeding and is contraindicated in patients with active gastrointestinal bleeding or severe clotting disorders.

Common Adverse Reactions

Commonly reported side effects often relate to the caffeine component and include nervousness, sleeplessness, and nausea. Other reported reactions involve the nervous system (e.g., headache, dizziness) and gastrointestinal tract (e.g., abdominal pain).

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose involving the Acetaminophen, Aspirin, and Caffeine combination is a condition with documented potential for severe, life-threatening outcomes, requiring an immediate professional response. Officially documented manifestations include signs of gastrointestinal distress, such as nausea, vomiting, and abdominal pain, along with CNS effects like tremors and agitation. High levels of salicylate component toxicity may present as tinnitus (ringing in the ears) or hearing loss.

Regulatory authorities mandate that overdose is a critical medical emergency. Prompt medical attention is critical for all individuals, including adults and children, even if no signs or symptoms are immediately noticeable. The required immediate action is to get medical help or contact a Poison Control Center right away.

Severe outcomes documented in official labeling include severe liver damage and liver failure due to the Acetaminophen component, and a potential for severe stomach bleeding from the Aspirin component, all of which carry a risk of death. Hospital monitoring is required, and official management procedures include the administration of the N-acetylcysteine antidote to mitigate hepatotoxicity. The risk of severe liver damage is officially noted to be increased when the medication is consumed concurrently with three or more alcoholic drinks daily.

Therapeutic Uses of Excedrin

What Excedrin Treats: Main Uses and Benefits

The Acetaminophen, Aspirin, and Caffeine combination is generally used in situations involving certain distressing symptoms, contributing to easing the overall symptom load during symptomatic periods. The combination is indicated for use in situations involving a range of discomforts.


This medication is applied across therapeutic domains where short-term symptom management is appropriate, playing a role in managing the disruptive pain of tension headaches and migraine headaches. It is also commonly used across conditions presenting with episodic or fluctuating manifestations of pain, including muscular aches, minor arthritis pain, toothache, and discomfort related to menstrual cramps.

The therapeutic scope extends to conditions presenting with systemic discomfort, such as the fever and body aches that often accompany a cold. This provides support that may assist with managing symptoms that interfere with daily comfort. Supportive relief is described as follows:

“This type of medication is commonly used to help with symptomatic relief that assists patients with managing difficult episodes and contributes to improved comfort during symptomatic phases.”

Quick Fact: Relief for Acute Pain and Tension

The medication is relevant for use in conditions characterized by periods of heightened symptoms and is applied in settings that involve acute or unstable symptom patterns, assisting in easing the overall symptom load during phases of increased distress or discomfort.

Regulatory References

  1. NIH DailyMed Drug Facts for Acetaminophen, Aspirin, and Caffeine

Eligibility and Restrictions for Use

Population Eligibility Rules

Standard regulatory labeling permits use of the Acetaminophen, Aspirin, and Caffeine combination product for adults and children 12 years of age and over. However, eligibility is strictly defined by both absolute prohibitions and conditional use requirements.


Absolute Contraindications

The medicine must not be used by individuals with a known allergy to any of its ingredients or by patients concurrently taking any other acetaminophen-containing drug. Use is also strictly prohibited for children and teenagers recovering from chickenpox or flu-like symptoms due to the risk of Reye's syndrome. Furthermore, regulatory documents state that use is contraindicated during the last trimester of pregnancy (at 20 weeks gestation or later).


Restricted and Conditional Use

Consultation with a health professional is mandated prior to use for patients with certain pre-existing conditions. These conditions include liver disease, kidney disease, stomach ulcers or bleeding problems, high blood pressure, heart disease, or asthma. Use is also restricted for individuals age 60 or older and those who consume three or more alcoholic drinks daily. Patients who are pregnant or breastfeeding must also consult a health professional before use.

What should I know about interactions with other medicines?

The officially documented interaction profile for this combination medicine is defined by pharmacokinetic and pharmacodynamic restrictions detailed in authoritative regulatory labeling. The profile addresses interactions that modify plasma concentration, amplify risk, or are explicitly prohibited.


Documented Contraindications and Restrictions

  • Monoamine Oxidase Inhibitors (MAOIs): Co-administration is formally contraindicated. A mandatory two-week separation period is required after discontinuing an MAOI before this product can be administered.
  • Alcohol: Consumption of three or more alcoholic drinks daily is contraindicated due to the significantly increased risk of liver damage and gastrointestinal bleeding.
  • Other NSAIDs/Aspirin: Concurrent use with other Nonsteroidal Anti-inflammatory Drugs or aspirin-containing products is restricted due to the heightened, additive risk of gastrointestinal ulceration and bleeding.

Pharmacokinetic and Pharmacodynamic Effects

  • Bleeding Risk: Co-administration with Anticoagulants (e.g., Warfarin) or Antiplatelet Agents may cause an additive pharmacodynamic effect, increasing the potential for bleeding.
  • Exposure Alterations: The clearance of the caffeine component is reduced by CYP1A2 Inhibitors (e.g., Cimetidine, Fluoroquinolones), resulting in increased plasma concentrations. Conversely, Enzyme Inducers (e.g., Phenytoin) may reduce acetaminophen exposure.
  • Uricosuric Agents: The aspirin component may reduce the therapeutic effect of uricosuric agents (e.g., Probenecid) due to a pharmacodynamic interaction.

Population-Specific Notes

Regulatory documentation notes that Elderly patients have an increased risk of serious gastrointestinal adverse events when the aspirin component is co-administered with certain interacting agents. Patients with hepatic impairment are also cited as having a heightened interaction risk related to adverse outcomes from acetaminophen.

Mechanism of Action

The mechanism of action involves the complementary pharmacodynamic effects of Acetaminophen and Caffeine, targeting key central and vascular pathways.

Central Enzymatic Inhibition of Prostaglandin Synthesis

The Acetaminophen component primarily acts in the CNS and hypothalamus by functioning as a peroxide-sensitive inhibitor of Cyclooxygenase (COX) enzymes. This inhibition suppresses the production of the signaling molecule prostaglandin E2 ( PGE2) in these central areas. This enzymatic modulation leads to a reduced sensitization of central nociceptive pathways and the resetting of the body’s hypothalamic thermostatic set point, thereby influencing nociception and thermoregulatory function.

Adenosine Receptor Antagonism and Adjuvancy

The Caffeine component acts as a non-selective competitive antagonist at adenosine receptors ( A1 and A2 A) in the CNS and on cranial blood vessels. By blocking the effects of endogenous adenosine, Caffeine increases neuronal excitability and directly causes cerebral vasoconstriction. Mechanistically, this action supports the central modulation of nociception by Acetaminophen, consistent with an analgesic adjunct effect, where the receptor antagonism complements the enzyme inhibition, contributing to the drug's overall profile of central pathway modulation.

Dosage and Administration Information

How to Use Excedrin: Administration Guidelines

This section describes the high-level instructions for the use of the fixed-dose combination product containing Acetaminophen (250 mg), Aspirin (250 mg), and Caffeine (65 mg). The medicine is administered via the oral route in the form of a caplet or tablet.


Dosing and Frequency Patterns

Dosing regimens vary based on the specific use pattern.

Usage Pattern Single Dose Maximum Daily Limit (24 Hours)
Acute Migraine Two caplets (taken at symptom onset) Two caplets
Minor Aches/Pains Two caplets/tablets Eight caplets/tablets

For minor aches, the two-caplet dose may be repeated every six hours. The specific limit for acute migraine is a single two-caplet dose, which is not to be repeated within the 24-hour period.


Procedural and Duration Constraints

The administration of each dose unit must occur with a full glass of water. A key procedural constraint requires users to limit the concurrent intake of other products containing caffeine.

Regarding the duration of use, the medicine is restricted to short-term courses: it should not be used for more than 10 days for pain or 3 days for fever. Furthermore, use for headache relief is constrained to fewer than 10 days per month. Patients under 18 years of age (for migraine) or under 12 years of age (for general pain) are directed to consult a healthcare professional before use, establishing specific age-group parameters for administration. This structure defines the standardized use protocol.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Excedrin

Evidence for Acute Migraine Headache

Research on the Acetaminophen, Aspirin, and Caffeine combination was observed in settings related to acute migraine headache. Research has explored how symptoms change over time in adult populations. These trials included individuals experiencing moderate to severe migraine pain. The main goals of this research examined whether participants achieved a pain-free status and the reduction of pain intensity to mild or none at the 2-hour mark post-dose. Furthermore, studies monitored outcomes related to systemic or functional imbalance, such as the relief of associated migraine symptoms like sensitivity to light and sound. The findings describe patterns observed in the studies where changes in these measured outcomes were reported compared to taking an inactive substance (placebo).

Evidence for Episodic Tension-Type Headache

The combination was also evaluated in studies exploring episodic tension-type headache (TTH), a condition characterized by fluctuating or episodic manifestations. This research was conducted through controlled trials, including specialized crossover studies, which compared the combination drug against its single components and inactive controls. The data show patterns related to the time taken to observe initial pain relief among study participants when the combination was used. A key limitation of this research is that it mainly focuses on episodic TTH, and data for certain groups remain insufficient regarding chronic or high-frequency tension headache patterns.

Duration of Evidence: Short-Term vs. Long-Term Studies

The majority of studies on the Acetaminophen/Aspirin/Caffeine combination was conducted during periods of increased symptom activity and are designed to research short-term symptom changes. The available evidence provides insight into the acute change in pain and functional measures within the first few hours following a single administration. However, the long-term effects are not fully established. Follow-up durations were limited in the pivotal trials, meaning data describing the durability of relief or the consequences of frequent, repeated use over extended periods are scarce. Research so far suggests that the current body of evidence is primarily tailored to understanding how the combination was observed in an acute episode, but it does not fully characterize its profile for chronic management.

Key Studies & References DailyMed Drug Facts for Acetaminophen, Aspirin, and Caffeine (Excedrin)

Frequently Asked Questions (FAQ)

Common questions about Excedrin (FAQ)

Q: How quickly does Excedrin usually start working for a headache?

A: Official information indicates that clinical trials observed the onset of relief for some individuals in as little as 15 minutes after taking the medicine. For research purposes, key outcomes related to pain reduction are typically measured at the 2-hour mark post-dose.

Q: Are there any specific supplements or foods that should not be taken with Excedrin?

A: Regulatory documents state that consumption of three or more alcoholic drinks daily is formally contraindicated due to a significantly increased risk of adverse events. Regulatory labeling indicates that concurrent intake of other products containing caffeine should be limited, as excessive amounts can be associated with side effects such as nervousness, irritability, and rapid heart beat.

Q: What kind of research has been done on Excedrin in people over 65?

A: Regulatory labeling does not specifically detail dedicated clinical studies conducted exclusively in this older population. However, it does note that individuals age 60 or older have an increased risk of stomach bleeding due to one of the ingredients. The official documentation requires consultation with a health professional for individuals in this age group before use.

Q: Are there specific symptoms that mean a person should stop taking Excedrin right away?

A: The product's warnings specify reasons for stopping use immediately, which include signs of a severe allergic reaction (such as hives or facial swelling), stomach bleeding (such as bloody or black stools, or vomiting blood), or a feeling of being faint. Ringing in the ears or loss of hearing are also listed as reasons to stop use and seek medical help.

Q: What is the main reason official documents advise against using Excedrin during the last three months of pregnancy?

A: The restriction during the last trimester of pregnancy is linked to the aspirin component, which is a type of medicine known as an NSAID. Using an NSAID late in pregnancy can cause fetal cardiac complications such as the premature closure of the ductus arteriosus, and may also increase the risk of maternal bleeding during delivery.

Q: Why is one of the ingredients sometimes described as a 'blood thinner'?

A: This description relates to the aspirin component. Regulatory information indicates that aspirin works by impairing platelet aggregation, which is the biological process that allows blood to clot. This action is why the medicine is noted to increase the potential for bleeding, particularly when taken with other medicines that affect clotting.

Q: Is Excedrin designed to prevent headaches, or only to treat them when they happen?

A: The medicine is officially labeled for the temporary relief of minor aches, pains, and migraine headaches, indicating its role is for acute treatment. Regulatory guidance emphasizes that to prevent the development of medication overuse headaches, use for headache relief should be strictly limited to no more than 10 days per month.

Q: What is the main difference between Excedrin and plain Tylenol (acetaminophen)?

A: Excedrin is a fixed-dose combination product containing three active ingredients: Acetaminophen, Aspirin (an NSAID), and Caffeine. The key difference is that plain Tylenol contains only the single active ingredient, Acetaminophen, while Excedrin is a fixed-dose combination product.

Q: Does caffeine in Excedrin make headaches worse when the medicine wears off?

A: Regulatory guidance includes strict limitations on use intended to prevent a condition known as medication overuse headache (MOH). Official documentation notes that using the product for headache relief more than 10 days per month may lead to these headaches, sometimes described as rebound headaches.

Q: What does 'NSAID' mean in relation to one of the ingredients in Excedrin?

A: NSAID is an abbreviation for Nonsteroidal Anti-inflammatory Drug. Aspirin, one of the active ingredients in this combination product, is classified as an NSAID. For this reason, official labeling includes a Stomach Bleeding Warning related to the ingredient.

Q: Is the amount of caffeine in Excedrin similar to a cup of coffee?

A: Yes, regulatory labeling specifically addresses this common question. The official label advises users to limit concurrent caffeine intake, noting that the maximum recommended single dose contains a concentration of caffeine roughly equivalent to that found in one cup of coffee.

Q: What does the term 'platelet aggregation' mean in the context of Excedrin’s ingredients?

A: Platelet aggregation is the biological process where small blood cells called platelets clump together to form a clot, which helps stop bleeding. The aspirin component in the medicine impairs this process, which is why official documents warn about a potential increase in bleeding risk.

Q: Is it necessary to take Excedrin with food, according to official information?

A: The official administration direction in regulatory documents mandates taking each dose with a full glass of water. The regulatory label does not strictly require the medicine to be taken with food, though consulting a health professional may be advised if the medicine causes stomach upset.

Q: Can Excedrin cause ringing in the ears (tinnitus), and is this common?

A: Official product information specifies that ringing in the ears or a loss of hearing are possible adverse effects of the medication. These symptoms are listed as specific reasons for a user to immediately stop use and seek medical advice.

Q: Are there any known issues with taking Excedrin before or after surgery?

A: Due to the aspirin component, which increases the risk of bleeding, regulatory advice and medical practice typically recommend discontinuing use of the drug for a specific period of time prior to major surgery. This timing is a matter for discussion with a patient’s surgical team.

Q: Are there non-headache pain conditions where Excedrin has been studied?

A: According to the official product label, the medicine is indicated for use in a range of general pain conditions beyond headache and migraine. These include temporarily relieving minor aches and pains associated with a cold, arthritis, muscular aches, toothache, and premenstrual and menstrual cramps.

Q: Is it true that taking Excedrin can affect blood tests?

A: Official guidance related to the active ingredients notes the potential for interference with certain laboratory results. The components, particularly aspirin and acetaminophen, may potentially affect blood test outcomes. It is important for patients to inform their healthcare provider of all medicines used before any lab work.

Q: Is there a different type of Excedrin for body pain versus headache pain?

A: The combination formula (Acetaminophen, Aspirin, and Caffeine) is a single, approved formulation that is labeled to relieve both headache pain and general minor aches and pains (body pain). The regulatory label provides different dosing patterns for the acute treatment of migraines versus the treatment of minor aches.

Q: Does Excedrin have any known effects on mood or anxiety?

A: Due to the caffeine component, regulatory documents list common side effects that include nervousness, irritability, and sleeplessness. Adverse event reports related to the medicine have also included documented feelings of anxiety or being restless.

How should Excedrin be stored and disposed of?

How to Store and Dispose of Excedrin

Excedrin (acetaminophen, aspirin, and caffeine) must be stored at controlled room temperature, specifically between 20^circ-25 C (68^circ-77 F), with protection from excess heat and moisture. The regulatory label requires that the container cap be closed tightly after use to maintain stability and prevent degradation.

Safety and Disposal

It is mandatory to Keep out of reach of children to prevent accidental overdose. For disposal of expired or unused medication, the preferred method is a drug take-back program. As an alternative for non-flush-list medicines, the product may be mixed with an undesirable substance (like dirt or coffee grounds), sealed in a container, and discarded in the household trash. The medicine should not be flushed down the toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Excedrin found in:

A-Z Index: